medigraphic.com
SPANISH

Alergia, Asma e Inmunología Pediátricas

Órgano Oficial del Colegio Mexicano de Alergia, Asma e Inmunología Pediátrica y de la Asociación Latinoamericana de Pediatría
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2013, Number 1

Next >>

Alerg Asma Inmunol Pediatr 2013; 22 (1)

Colaborando para mejorar la calidad de vida de personas con inmunodefi ciencias primarias: Semana Internacional de Inmunodefi ciencias Primarias 2013

Sorensen R, Etzioni A, Aziz A, Zeiger JB
Full text How to cite this article

Language: Spanish
References: 16
Page: 3-7
PDF size: 114.71 Kb.


Key words:

No keywords

ABSTRACT

No abstract


REFERENCES

  1. Eades-Perner AM, Gathman B, Kner V, Guzman D, Veit D, Kindle G et al. ESID Registry Working Party. The European internet-based patient and research database for primary immunodeficiencies: results 2004-06. Clin Exp Immunol. 2007; 147: 306-312.

  2. Gathmann B, Grimbacher B, Beauté J, Dudoit Y, Mahlaoui N, Fischer A et al. ESID Registry Working Party. The European internet-based patient and research database for primary immunodeficiencies: results 2006-2008. Clin Exp Immunol. 2009; 157 (Suppl 1): 3-11.

  3. Gathmann B, Binder N, Ehl S, Kindle G; ESID Registry Working Party. The European internet-based patient and research database for primary immunodeficiencies: update 2011. Clin Exp Immunol. 2012; 167: 479-491.

  4. de Vries E; European Society for Immunodeficiencies (ESID) members. Patient-centred screening for primary immunodeficiency, a multi-stage diagnostic protocol designed for non-immunologists: 2011 update. Clin Exp Immunol. 2012; 167: 108-119.

  5. Maródi L, J Project Study Group. The creation and progress of the J Project in Eastern and Central Europe. Ann NY Acad Sci. 2011; 1238: 65-73.

  6. Zelazko M, Carneiro-Sampaio M, Cornejo LM, Garcia OD, Porras MO, Berrón PR et al. Primary immunodeficiency diseases in the Latin America: first report from eight countries participating in LAGID. J Clin Immunol. 1998; 18: 161-166.

  7. Leiva LE, Zelazco M, Oleastro M, Carneiro-Sampaio M, Condino-Neto A, Costa-Carvalho BT et al. Primary immunodeficiency diseases in Latin America: the second report of the LAGID registry. J Clin Immunol. 2007; 27: 101-108.

  8. Errante PR, Franco JL, Espinosa-Rosales FJ, Sorensen R, Condino-Neto A. Advances in primary immunodeficiency diseases in Latin America: epidemiology, research, and perspectives. Ann N Y Acad Sci. 2012; 1250: 62-72.

  9. Condino-Neto A, Franco JL, Espinosa-Rosales FJ, Leiva LE, King A, Porras O et al. Advancing the management of primary immunodeficiency diseases in Latin America: Latin American Society for Immunodeficiencies (LASID) Initiatives. Allergol Immunopathol (Madr). 2012; 40: 187-193.

  10. Barbouche MR, Galal N, Ben Mustapha I, Jeddane L, Mellouli F, Ailal F et al. Primary immunodeficiencies in highly consanguineous North African populations. Ann N Y Acad Sci. 2011; 1238: 42-52.

  11. Al-Muhsen S, Alsum Z. Primary immunodeficiency diseases in the Middle East. Ann N Y Acad Sci. 2012; 1250: 56-61.

  12. Hassan A, Booth C, Brightwell A, Allwood Z, Veys P, Rao K et al. Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency. Blood. 2012; 120: 3615-3624.

  13. Bousfiha AA, Jeddane L, Ailal F, Benhsaien I, Mahlaoui N, Casanova JL et al. Primary immunodeficiency diseases worldwide: more common than generally thought. J Clin Immunol. 2013; 33: 1-7.

  14. Mitchell R, Nivison-Smith I, Anazodo A, Tiedemann K, Shaw P, Teague L et al. Outcomes of hematopoietic stem cell transplantation in primary immunodeficiency: a report from the Australian and New Zealand Children’s Haematology Oncology Group and the Australasian Bone Marrow Transplant Recipient Registry. Biol Blood Marrow Transplant. 2013; 19: 338-343.

  15. Kirkpatrick P, Riminton S. Primary immunodeficiency diseases in Australia and New Zealand. J Clin Immunol. 2007; 27: 517-524.

  16. National Blood Authority National Report on the Issue and Use of Intravenous Immunoglobulin (IVIg) for 2010–2011. Canberra; National Blood Authority [www.nba.gov.au/ivig/ivig-report-10-11_amended_dec2012.pdf; último acceso el 5 de marzo de 2013].




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Alerg Asma Inmunol Pediatr. 2013;22